Regeneration protocols and markers after CRISPR editing in recalcitrant plants

[LaylaP]

I'm a graduate student in molecular biology, and my thesis project involves using CRISPR gene editing to knock out a specific regulatory gene in a plant model. While I've successfully designed the gRNA and confirmed editing via sequencing in callus tissue, I'm struggling with the regeneration of whole, fertile plants from these edited cells. For others working with plant systems, what regeneration protocols or media adjustments have you found most effective for recalcitrant species after CRISPR treatment? How do you troubleshoot when you get good editing efficiency but poor regeneration, and are there specific markers or screening methods you use early in the process to identify successfully edited lines that are also regeneration-competent?

[Jerry60]

That regeneration bottleneck after CRISPR editing is extremely common. If you’ve got good editing in callus but no plantlets, consider the possibility that the targeted regulatory gene contributes to meristem formation or tissue culture responsiveness. In practice, researchers explore alternatives like tissue-specific or inducible edits to avoid impacting regeneration, or test partial loss-of-function alleles to see if you can still drive the phenotype without killing regeneration. Keeping a parallel, non-edited control line can help you parse effects of the edit from culture conditions.

[Camila.J]

A practical plan is to establish a baseline regeneration using a non-edited line or a closely related species to understand the culture system. Then try multiple explant sources (e.g., leaf discs, cotyledons, or embryo axes) and consider different regeneration routes (organogenesis vs somatic embryogenesis) to see which yields plantlets. Document responses in a simple log and compare regeneration rate and health across conditions before investing in thorough genotyping.

[Ronald.M]

Marker strategies: early genotyping on regenerating tissue to check the edit is present and consistent; look for mosaicism; use non-destructive reporters if available to gauge transformation/regeneration progress. If you also want to identify regeneration-competent lines, you could screen for expression or phenotypic markers associated with robust regeneration in your species (e.g., wound response genes) and correlate with regeneration outcomes. But avoid relying solely on a single marker; combine genotypic checks with phenotypic regenerative potential.

[Justin_B]

Troubleshooting angle: the regulatory gene you’re targeting may influence callus viability or organogenesis; if so, you might switch to an approach that limits expression to a particular tissue or developmental stage, or use an inducible CRISPR system to pause editing until after regeneration. Also re-evaluate media supplements and growth regulator balance at a high level, maybe by testing a different induction cue (but keep it conceptual).

[Jack.R]

Good resources: look for recent reviews on plant regeneration and CRISPR in plants; check if your institution's core facility has published regeneration benchmarks; compare with model species like Arabidopsis or rice CRISPR lines that discuss regeneration efficiency. Reach out to the broader community through lab groups or institutional biosafety committees for guidelines; reading primary literature with 'regeneration' and 'CRISPR' in the keywords will help you identify conditions that other labs have reported.